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The rapid emergence of SARS‑CoV‑2, the causative agent of COVID‑19, and its dissemination globally 
has caused an unprecedented strain on public health. Animal models are urgently being developed 
for SARS‑CoV‑2 to aid rational design of vaccines and therapeutics. Immunohistochemistry and 
in situ hybridisation techniques that facilitate reliable and reproducible detection of SARS‑CoV 
and SARS‑CoV‑2 viral products in formalin‑fixed paraffin‑embedded (FFPE) specimens would be of 
great utility. A selection of commercial antibodies generated against SARS‑CoV spike protein and 
nucleoprotein, double stranded RNA, and RNA probe for spike genes were evaluated for the ability to 
detect FFPE infected cells. We also tested both heat‑ and enzymatic‑mediated virus antigen retrieval 
methods to determine the optimal virus antigen recovery as well as identifying alternative retrieval 
methods to enable flexibility of IHC methods. In addition to using native virus infected cells as positive 
control material, the evaluation of non‑infected cells expressing coronavirus (SARS, MERS) spike 
as a biosecure alternative to assays involving live virus was undertaken. Optimized protocols were 
successfully applied to experimental animal‑derived tissues. The diverse techniques for virus detection 
and control material generation demonstrated in this study can be applied to investigations of 
coronavirus pathogenesis and therapeutic research in animal models.
A novel coronavirus, SARS-CoV-2, emerged in Central China late 2019, primarily causing a respiratory disease 
termed COVID-191. This virus spread rapidly across the globe and was declared a pandemic by the WHO on 
the 11th of March 2020. As of October 2020, the pandemic has caused 40 million infections including 1 million 
deaths  globally2.
SARS-CoV-2 is a Betacoronavirus classified under the order Nidovirales and family Coronaviridae, with a 
RNA genome that is closely related to SARS-CoV3. SARS-CoV-2 and SARS-CoV cellular entry is dependent on 
the receptor angiotensin-converting enzyme 2 (ACE2). Following the activation of spike protein by the cellular 
priming proteases TMPRSS2 and cathepsins, fusion of viral envelope and cellular membranes occur, allowing 
the viral genome to enter the host  cell4. The spike protein, consisting of S1 and S2 subunits, is a major target 
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for antibody-mediated neutralisation in which immunogenic epitopes reside within the S1  domain5,6. During 
coronavirus replication, nucleoprotein is the most abundantly expressed proteins, followed by the  spike7. In addi-
tion, during the virus replication cycle, double-stranded RNA (dsRNA) is produced as an intermediate  product8.
The pathogenicity and transmission dynamics of SARS-CoV-2 differs from SARS-CoV9 and there is an urgent 
requirement to address virological and pathological questions using animal models for human disease and for 
susceptible animal species. Although not an exhaustive list, experimental investigations have been performed 
in animal models including  ferrets10, Cynomolgus  macaques11, Rhesus  macaques12, African green  monkeys13, 
Egyptian fruit  bats14, golden Syrian  hamsters15, transgenic hACE2  mice16,  cats17,18 and  dogs18. Currently, there 
are limited reports on the use of immunohistochemistry (IHC) and in situ hybridisation (ISH) targeting virus 
antigens and genes to define virus-host interactions following in vivo  experiments11,14 due to a scarcity of suitable 
reagents and tissues for test development.
Here the suitability of antibodies and RNA probes for the detection of SARS coronaviruses present in for-
malin-fixed paraffin-embedded (FFPE) specimens using IHC and ISH, respectively, is reported. In addition, 
options for control materials for test development and quality assurance are described. Subsequently, the com-
parative utility of these optimised assays on tissues from infected animals and the cellular distribution of virus 
components is demonstrated.
Results
Detection of SARS‑CoV and SARS‑CoV‑2 antigens. Several commercially available antibodies to 
SARS-CoV were evaluated using heat (ph6 or 9) and enzymatic-mediated epitope unmasking technique to 
detect the presence of virus antigens in FFPE native virus infected cell pellets (Table 1). A rabbit monoclonal 
(mAb; Sino Biological 40150-R007) spike antibody and rabbit polyclonal nucleoprotein antibody (Sino Bio-
logical, 40143-T62) were identified to be suitable for IHC on FFPE cell pellets in which specific cytoplasmic 
chromogen granules were observed in SARS-CoV and SARS-CoV-2 infected cells but not on uninfected cells 
(Fig. 1a–f). The rabbit monoclonal (mAb; Sino Biological 40150-R007) spike antibody is compatible with either 
pH9 or 6 retrieval method, whereas rabbit polyclonal nucleoprotein antibody (Sino Biological, 40,143-T62) can 
be applied on virus antigen retrieved using either heated pH6 buffer or proteinase (Table 1). The detection of 
nucleoprotein using the same antibody and antigen retrieval method in a different institution (EMC) also dem-
onstrated reproducible immunolabelling (Supp. Figure 1a, b).
Alongside developing the IHC technique to detect SARS-CoV specific antigens, the IHC detection of 
dsRNA—a viral replicative intermediate was evaluated. Among the three antibodies evaluated, both the J2 
recombinant clone raised in mouse and rabbit was able to detect dsRNA in infected cell pellets with cytoplasmic 
chromogen deposits (Fig. 1g,h; Supp. Figure 1c, d). However, the amount of immunolabelling was not abundant 
in comparison to SARS specific antigen detection method. The other clone, 9D5, did not generate chromogen 
deposits with IHC. The cell pellets were also evaluated for non-specific binding using an alphacoronavirus anti-
body against Feline infectious peritonitis virus (FIPV). No chromogen was detected in uninfected and SARS-CoV 
infected cells using the FIPV antibody (not shown).
Table 1.  Antibodies evaluated for immunoreactivity against formalin-fixed paraffin-embedded SARS 
coronavirus infected cell pellets by immunohistochemistry. n/a not applicable, dsRNA double stranded RNA, 
FIPV feline infectious peritonitis virus.
Antibody
Species and 
clonality Source
Catalogue 
number Immunogen
Suitability with antigen retrievals for detection Optimal 
dilution ReferencespH 9 pH 6 Proteinase No retrieval
Anti-SARS 
spike
Rabbit mono-
clonal Sino biological 40150-R007
SARS-CoV 
spike S1 recep-
tor binding 
domain
Yes Yes, weaker than pH9 Non-specific No 1:400–800
Not suitable in 
earlier  report24
Anti-SARS 
nucleoprotein
Rabbit mono-
clonal Sino biological 40143-R019
Recombinant 
SARS-CoV 
nucleoprotein
Non-specific Non-specific Non-specific n/a n/a –
Anti-SARS 
nucleoprotein
Rabbit poly-
clonal Sino biological 40143-T62
Recombinant 
SARS-CoV 
nucleoprotein
Non-specific Yes Yes n/a 1:1000–1500
Used in cell 
pellet and ani-
mal  tissues11, 24
Anti-dsRNA 
[J2]
Rabbit mono-
clonal
Absolute 
antibody Ab01299-23.0 L-dsRNA Yes
Yes, weaker 
than pH9 No n/a 1:100 –
Anti-dsRNA 
[J2]
Mouse mono-
clonal Scicons 10010500 L-dsRNA pH 8 No No n/a 1:100
29
Anti-dsRNA 
[9D5]
Mouse mono-
clonal
Absolute 
antibody Ab00458-1.1
RDV-RNA-
methylated 
bovine serum 
albumin 
complex
No No No n/a n/a –
Anti-FIPV Mouse mono-clonal Invitrogen FIPV3-70 FIPV No No No n/a 1:100
34
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Detection of RNA encoding SARS‑CoV and SARS‑CoV‑2 spike protein. One RNAScope® probe 
was evaluated for the ability to detect SARS coronavirus RNA in FFPE cell pellets. The V-nCoV2019-5 probe did 
not produce labelling to SARS-CoV (Fig. 2a) but successfully labelled SARS-CoV-2 infected cell pellets (Fig. 2b). 
Labelling was not observed on uninfected cell pellets (Fig. 2c).
Detection of SARS‑CoV and SARS‑CoV‑2 pseudotype virus in producer cells. To determine 
if FFPE in vitro generated pseudotype virus expressing recombinant spike protein would be suitable for IHC 
detection, IHC using the spike mAb identified above was performed on producer cells consisting of lentiviral 
pseudotype virus expressing either SARS-CoV, SARS-CoV-2 or MERS spike protein. In this assay, the spike 
mAb was able to detect both SARS-CoV and SARS-CoV-2, displaying specific cytoplasmic and membranous 
chromogen deposits (Fig. 3a,b). Immunolabelling was not detectable for MERS spike expressing cells (Fig. 3c) 
or untransfected cells (Fig. 3d).
Application of IHC and ISH on animal tissues. IHC and ISH methods developed and optimised on 
FFPE cell pellets were tested on nasal turbinates of experimentally derived SARS-CoV-2 infected ferret. Using 
the spike antibody, immunolabelling was observed specifically labelling the luminal cells in the olfactory epithe-
lial mucosa (Fig. 4a). Nucleoprotein labelling (Fig. 4b) was more ubiquitous in the cytoplasm compared to spike 
labelling. dsRNA immunolabelling was limited to cytoplasm of the perinuclear region (Fig. 4c), which corre-
sponds to coronavirus replication  site19. As for ISH against spike gene, chromogen was deposited diffusely within 
the cytoplasm of the infected epithelial cells (Fig. 4d). Serial sections immunolabelled with nucleoprotein, spike 
or dsRNA antibody (Fig. 4a,c), or spike ISH showed consistent labelling in infected cell population, confirming 
the specificity of the detection of SARS-CoV-2 in animal tissues.
Discussion
In this report, we described optimized methods for antigen and RNA detection for SARS-CoV and SARS-
CoV-2 present in FFPE specimens. Using antibodies raised against SARS-CoV spike and nucleoprotein, we 
were able to detect the antigens of both SARS-CoV and SARS-CoV-2 present in infected cells and processed for 
Figure 1.  Immunohistochemical labelling of FFPE SARS-CoV and SARS-CoV-2 infected cells and uninfected 
cells. Immunodetection performed using SARS-CoV spike rabbit monoclonal antibody (a–c), SARS-CoV 
nucleoprotein rabbit polyclonal antibody (d–f) and double-stranded RNA (dsRNA) rabbit monoclonal antibody 
(g–i). Scale bars, 20 µm.
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histology. In addition,  RNAScope® probe designed specifically for SARS-CoV-2 labelled specifically to cognate 
virus strain. The detection of a virus replication product, dsRNA, was also evident on IHC. Furthermore, we 
utilised FFPE pseudotype virus producer cells for SARS-CoV spike IHC and demonstrated the specificity of 
immunolabelling for both strains of SARS virus.
In IHC or ISH applications, positive control materials are needed to be developed and validated for pathol-
ogy investigations to ensure the quality of results produced. Susceptible cell lines infected with native virus can 
be generated for such purpose without a requirement for animal tissues. However, this can be problematic for 
laboratories that lack high containment facilities required to conduct in vitro work. As an alternative, institu-
tions with the relevant genetic engineering expertise can generate proteins expressed in cell culture through 
transfection and pseudotype  system20, which can be used as an alternative to live virus work to demonstrate the 
detection of expressed viral proteins following formalin fixation and paraffin embedding.
Although formalin can reliably inactivate infectious agents, fixation can lead to cross-linking of epitopes and 
impede antibody binding. Enzymatic- or heat-mediated (pH 6 or 9 buffer) antigen retrieval can be applied to re-
expose epitopes although the biochemical impact of these methods have not been  assessed21. Often, only a single 
antigen-retrieval method, commonly heat-mediated retrieval, is described for the detection of SARS-CoV-2 virus 
 antigen22,23. The spike antibody used in our current study was previously reported as being unsuitable for IHC 
on FFPE  sections24. Here, pH 9 retrieval was demonstrated to be more efficient than pH 6 when attempting to 
unmask spike epitopes. As for nucleoprotein detection, pH 6 antigen retrieval was reproducible in two separate 
institutional settings. Further, the suitability of protease antigen retrieval for the detection of nucleoprotein was 
demonstrated in our study. The versatility of heat- or enzymatic-mediated antigen retrieval for nucleoprotein 
antigen can provide greater flexibility for investigator to perform multilabelling against other antigen of interest.
As there is growing scientific interest in comparing the pathogenesis of SARS-CoV and SARS-CoV-2, we 
evaluated the ability of antibodies to cross-react to both virus strains. The spike S1 receptor binding domain 
(RBD) specific antibody was able to detect spike antigen in both native virus and expressed spike protein of SARS-
CoV. Although the RBDs of SARS-CoV and SARS-CoV-2 share only 76% amino acid  identity25, the detection 
with a single preparation of antibody suggests epitope conservation between the two strains assessed. In contrast, 
Figure 2.  In situ hybridisation (ISH) of FFPE cells infected with SARS-CoV and SARS-CoV-2 using 
 RNAScope®. ISH performed using RNA probes designed specific to SARS-CoV-2 spike RNA. SARS-CoV (a) 
and SARS-CoV-2 infected cells (b), uninfected cells (c). Scale bars, 20 µm.
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the observation that the SARS-CoV spike S1 antibody did not cross react and bind to the MERS spike protein is 
likely due to the low amino acid homology (33%) between SARS-CoV-2 and MERS-CoV26.
Conversely, the SARS coronavirus nucleoprotein amino acid is highly conserved between SARS-CoV and 
SARS-CoV-2 with 90% amino acid  identity27. This fact was supported by our finding that the nucleoprotein 
antibody cross-reacted with both viruses. Apart from detecting virus-specific proteins, the virus replicative inter-
mediate dsRNA can also be used to detect RNA viruses including  coronaviruses28. In addition to the ability to 
detect SARS-CoV as described  previously28, SARS-CoV-2 can also be detected by IHC using a dsRNA antibody. 
However, this will require infected cells as positive controls as dsRNA is only synthesised during virus replication.
The utility of these assays was also demonstrated in the detection of viral products in experimentally infected 
SARS-CoV-2 animal tissues. In the nasal turbinate epithelial cells, dsRNA was present in the peri-nuclear cyto-
plasm. Early virus replication involves the synthesis of negative-stranded genome template and dsRNA replica-
tive intermediate in which dsRNA was previously observed in the double-membrane vesicles of modified ER 
membranes situated in the perinuclear region using immungold staining  technique19. Our study demonstrated 
spike glycoprotein detection at the apical aspect of respiratory epithelial cells. The localisation was similar to a 
recent report of SARS-CoV-2 infection of intestinal  organoids29.
In conclusion, we have demonstrated the suitability of agarose-embedded infected or transfected cell pellets 
expressing target proteins, fixed and routinely processed for histopathology, in the development of in situ detec-
tion methods for the application in animal model research. This preliminary evaluation of virus detection in 
histological sections has demonstrated suitability of IHC and ISH on FFPE tissues, and importantly has provided 
knowledge on the spatial cellular distribution of virus components by conventional light microscopy. The detec-
tion of SARS coronavirus antigens and nucleic acids in a cell pellet platform also allowed the rapid development of 
pathology tools that can be applied in future assessments of SARS-CoV-2 pathogenesis and intervention studies.
Materials and methods
Cells and viruses. Vero E6 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM, Gibco) 
supplemented with 10% foetal calf serum (FCS), HEPES, sodium bicarbonate, penicillin (100 IU/mL) and strep-
tomycin (100 IU/mL). Human embryonic kidney (HEK) 293T-17 cells were grown in DMEM supplemented 
Figure 3.  Immunohistochemistry labelling of FFPE cells expressing SARS-CoV, SARS-CoV-2 and MERS spike 
proteins. Immunodetection performed using SARS-CoV spike rabbit monoclonal antibody on producer cells for 
SARS-CoV (a), SARS-CoV-2 (b) and MERS-CoV pseudotype virus (c) and non-transfected cells (d). Scale bars, 
20 µm.
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with FCS, penicillin (100 IU/mL) and streptomycin (100 IU/mL). Cells were grown at 37 °C in a humidified 
 CO2 incubator. SARS-CoV (isolate HKU-39849)29 and SARS-CoV-2 (isolate BetaCoV/Munich/BavPat1/2020; 
European Virus Archive Global #026V-03883)29 were used for in vitro work whilst SARS-CoV-2 (nCoV/Vic-
toria/1/2020) was used for in vivo  experimentation30. Both SARS-CoV and SARS-CoV-2 were propagated on 
VeroE6 (ATCC ® CRL 1586TM) cells in Opti-MEM I (1X) + GlutaMAX (Thermofisher), supplemented with peni-
cillin (100 IU/mL) and streptomycin (100 IU/mL) at 37 °C in a humidified  CO2 incubator. Stocks were produced 
by infecting VeroE6 cells at a multiplicity of infection (MOI) of 0.01 and incubating the cells for 72 h (hours). 
The culture supernatant was cleared by centrifugation and stored in aliquots at − 80  °C. Investigations using 
infectious virus were performed within the biosafety level 3 laboratory at the Erasmus Medical Centre (EMC), 
Netherlands.
Generation of virus infected cells. Vero E6 cells were inoculated with SARS-CoV and SARS-CoV-2 at 
a MOI of 0.3. After 24 h post-infection, cells were fixed with 10% neutral buffer formalin (NBF) along with a 
separate flask of non-infected cells.
Generation of virus pseudoparticle in producer cells. Recombinant spike protein was pseudotyped 
onto a lentiviral core as previously  described31,32. This was conducted in a BSL2 laboratory in APHA. Briefly, 
HEK 293T-17 cells were transfected with p8.91 (gag-pol), pCAGGS-s (full length SARS-CoV, SARS-CoV-2, or 
MERS spike), and pCSFLW. At 5 days post-transfection, cells were fixed with 10% NBF.
Preparation of cells for histology processing. Fixed monolayer of cells from in  vitro infection or 
transfection were scraped off flasks and centrifuged at 1500 g. Following removal of supernatant, cell pellets were 
Figure 4.  Immunohistochemistry and in situ hybridisation detection of SARS-CoV-2 and RNA on infected 
ferret tissues. Detection of spike protein (a), nucleoprotein (b) and dsRNA antigens (c) and spike RNA (d) 
labelling. Tissue shrinkage artefact with ISH pre-treatment (d). Scale bars, 20 µm.
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re-suspended in 2% agarose (Sigma) and allowed to set. Agarose-embedded cell pellets were then processed by 
routine histology method on a histology  processor33.
Animal experimental infection. In vivo experimentations were undertaken within the Advisory Com-
mittee on Dangerous Pathogens level 3 (ACDP3) certified animal complex of APHA, UK, in accordance to 
the Animal (Scientific Procedures) Act 1986. The animal experiment was approved by APHA Animal Welfare 
and Ethical Review Body (AWERB; HOL-PP3405816/1/001). Ferrets were inoculated intranasally with 1 ml of 
SARS-CoV-2 of 2 × 106 tissue culture infectious dose 50  (TCID50). Animals were humanely euthanised at pre-
determined time-points and tissues collected into 10% NBF.
Immunohistochemistry (IHC). Four micrometre thick sections were dewaxed and rehydrated through 
xylene and graded alcohol, respectively, quenched for endogenous peroxidase with 3% hydrogen peroxide in 
methanol (VWR International) for 15  min (minutes) at room temperature (RT), before epitope unmasking 
using pH6 (10 mM citric acid buffer, adjusted to pH6 with 1 M sodium hydroxide; Fisherscientific), pH9 target 
retrieval buffer (Envision FLEX, high pH; Dako) for 10 min at 97 °C, or proteinase XXIV (Sigma-Aldrich) for 
15 min at RT. Slides were blocked with normal goat serum for 30 min in RT (1/66 dilution; Vector Laboratories) 
and assembled into cover plates to facilitate IHC using the Shandon Sequenza system (Shandon). Samples were 
then incubated with a primary antibody at 4 °C overnight or 1 h at RT, followed by incubation with mouse- or 
rabbit-specific Envision™ polymer (Dako) for 30 min at RT and visualised using 3,3-diaminobenzidine (DAB) 
(Sigma Aldrich) for 10 min at RT. Tris-buffered saline with Tween (145 mM NaCl, 5 mM Tris(hydroxymethyl)
methylamine, 0.1% w/v Tween®20, adjusted to pH7.6 with 1 M HCl; Fisher Scientific; VWR International) were 
used for rinsing sections between incubations. Subsequently, sections were counterstained in Mayer’s haema-
toxylin (Surgipath), dehydrated in ethanol and xylene, and glass coverslips mounted using Dibutyl Phthalate 
Xylene.
In situ hybridisation (ISH). Twenty pairs of double Z proprietary RNA probes targeting the spike gene 
of SARS-CoV-2, (V-nCoV2019-5, catalogue no. 848569) were synthesised by Advanced Cell Diagnostics 
(ACD, USA). ISH was performed using the  RNAScope® 2.5 HD Brown Detection Kit (ACD) as per manufac-
turer’s instructions. Tissues were dewaxed and hydrated through xylene and alcohol, respectively, treated with 
 RNAscope® hydrogen peroxide (ACD) for 10 min at RT, and heat-mediated retrieval using Target Retrieval Solu-
tion (ACD) for 18 min at 97 °C and Protease Plus (ACD) for 10 min at 40 °C. RNA probes were then added to 
sections to allow hybridisation for 2 h at 40 °C and followed by 6 rounds of amplification with Hybridise Amp 
(ACD) at 40 °C, alternating between 30 and 15 min incubation, in the HybEZ™ oven (ACD). Slides were washed 
with 1× wash buffer (ACD) for 2 min at RT between incubations. Signal was detected using DAB. Sections were 
counter-stained with Mayer’s haematoxylin (Surgipath), dehydrated in ethanol and xylene, and glass coverslips 
mounted with Cytoseal (ACD).
Data availability
All data generated or analysed during this study are included in this published article (and its Supplementary 
Information files).
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